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Abstract
Purpose
To evaluate the relationship between comorbidities, medical cost, and surgical outcome in
patients with lumbar spinal stenosis (LSS) and diabetes mellitus (DM).
Methods
Data on patients with LSS (n = 14,298) were collected from the Korean National Health
Insurance Service database from 2005 to 2007. After 8 years of follow-up, a “DM group” (n =
3,478) and a “non-DM group” (n = 10,820) were compared according to outcome measures.
Cox proportional hazard regressions were performed to examine the relationship between
DM, hypertension (HTN), cardiovascular disease (CVD), chronic kidney disease (CKD),
cerebrovascular disease (CbVD), and surgery for LSS. The admission rate and medical
cost as well asthe overall survival rate for those who underwent lumbar surgery were also
assessed among patients with DM and LSS.
Results
Mortality was about 1.35 times higher in the DM group than in the non-DM group. Patients
with DM and comorbidities including HTN (hazard ratio [HR], 1.40; 95% confidence interval
[CI], 1.25–1.56; p<0.001), CVD (HR, 1.53; 95% CI, 1.36–1.73; p<0.001), CKD (HR, 3.18;
95% CI, 2.7–3.76; p<0.001), and CbVD (HR, 1.69; 95% CI, 1.49–1.91; p<0.001) showed an
increased risk of mortality. The mean hospitalization time and average medical cost of
patients with DM who underwent lumbar surgery were 60.8 days, and 7,127 USD, respec-
tively. This was 31.3 days longer, and 6,207 USD higher, respectively, than those of patients
with DM who underwent conservative treatment for LSS. Within the DM group, the survival
rate of surgical management of LSS had a significant tendency for positive prognosis com-
pared with those administered conservative treatment (p = 0.046).
PLOS ONE | https://doi.org/10.1371/journal.pone.0213858 March 15, 2019 1 / 11
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Lee CK, Choi SK, Shin DA, Yi S, Ha Y, Kim
KN, et al. (2019) Influence of diabetes mellitus on
patients with lumbar spinal stenosis: A nationwide
population-based study. PLoS ONE 14(3):
e0213858. https://doi.org/10.1371/journal.
pone.0213858
Editor: Gregory W.J. Hawryluk, University of Utah
Hospital, UNITED STATES
Received: November 1, 2018
Accepted: March 2, 2019
Published: March 15, 2019
Copyright: © 2019 Lee et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in
any medium, provided the original author and
source are credited.
Data Availability Statement: Data are available
from the Korea National Health Insurance Sharing
Service like this for researchers who meet the
criteria for access to data (https://nhiss.nhis.or.kr/
bd/ay/bdaya001iv.do;jsessionid=KiOt6ilaTGXMmR
1mbeeA9Ax7nJjIYDsKr4UJAJvHhNyo511E0PovM
1WfrGSaegL6.primrose22_servlet_engine1).
Funding: This research was supported by the Bisa
Research Grant of Keimyung University in 2018.
The funders had no role in study design, data
Conclusions
In patients with LSS, DM was associated both with poor prognosis (most significantly in
those with CKD), and increased medical cost in those who underwent surgery. Neverthe-
less, surgical treatment for LSS in patients with DM was related to favorable prognosis com-
pared with conservative treatment.
Introduction
Diabetes mellitus (DM) has become a major public health problem due to the increasing prev-
alence of associated morbidity and mortality [1]. The mortality rate of patients with DM is
reported to be 2–3 times higher than that of the general population [2,3]. The growth of the
DM population is particularly concerning to surgeons, as DM is linked to comorbidities and
surgical complications. DM is associated with various chronic diseases, such as hypertension
(HTN), cardiovascular disease (CVD), chronic kidney disease (CKD), and cerebrovascular dis-
ease (CbVD). DM also increases the risk of heart failure and coronary heart disease [4], and
the prevalence and progression rates of CKD are higher in patients with DM [5]. Conversely,
in one study, a decrease in cardiovascular mortality was associated with a decrease in ischemic
stroke mortality [6]. Moreover, an increased life expectancy and a higher DM incidence lead
to an increase in the number of chronic comorbid diseases [5].
Lumbar spinal stenosis (LSS) is also a serious health problem associated with aging. LSS can
cause moderate to severe pain, affecting the patient’s quality of life, and increasing healthcare
costs. Several studies have reported that DM is a risk factor of LSS [7,8], and there is a high
prevalence of LSS among patients with DM [9,10]. In studies about the relationship between
LSS and DM, one reported that surgical management of LSS in patients with DM was associ-
ated with decreased postoperative hemoglobin A1c level, resulting in increased physical activ-
ity [11], and another reported that patients with DM had a poorer outcome after spinal
surgery than controls, resulting in an increased rate of reoperation and hospitalization [12].
This study aimed to evaluate the relationship between prevalence, mortality, risk of comor-
bidity, medical cost, and surgical outcome in patients with DM who have LSS, using a large
national sample.
Material and methods
Database
From 2002 to 2013, this study used data from the Korean National Health Insurance Service
(KNHIS) database, which contained data on 1 million nationals who were randomly recruited
and nationally represented the entire Korean population. In Korea, almost all people are
obliged to enroll in the KNHIS. Approximately 97% of the Korean population are covered by
the mandatory health insurance system, and the remaining 3% are under Medicaid, a separate
program for the poor. Therefore, the Korean health insurance system holds large databases
that reflect the medical situation of the general population. These databases include diagnostic
codes, procedures, prescription drugs, personal information of the patient, hospital informa-
tion, and medical costs. The KNHIS uses the Korean Standard Classification of Diseases
(KCD), which was modified from the International Classification of Diseases (ICD).
Patient selection
This population-based retrospective cohort study was approved by the institutional review
board of Keimyung University Dongsan Medical Center (2018-04-035). The requirement of
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informed consent was waived by the institutional review board of Keimyung University Dong-
san Medical Center. Patients who were diagnosed with LSS in Korea between 2005 and 2007
were selected from the KNHIS database for analysis. The identification of cases is shown in Fig
1. First, we identified patients with a diagnostic code for LSS (M48.0, 48.05, 48.06, 48.07, 48.08,
48.09, 48.8, 48.85, 48.86, 48.87, 48.88, 48.89, 48.9, 48.95, 48.96, 48.97, 48.98, and 48.99). Second,
patients who were registered only once or twice for an LSS diagnostic code were eliminated to
exclude misdiagnosed patients. Third, we excluded patients who were<50 years old. Fourth,
we also excluded patients who underwent a previous lumbar spine surgery. Finally, we selected
14,298 patients (4,778 for 2005; 4,643 for 2006; and 4,877 for 2007) and divided them into two
groups (DM and non-DM).
Variables
Variables included LSS (determined by the KCD codes and diagnosed at least three times),
surgical management of LSS (determined by the KCD codes for LSS and operation codes
N1499, N2499, N0453, N0466, N0469, N1460, N1466, N1469, N2470, N0444, N0445, N0446,
and N0447, which include surgeries such as laminectomy, corpectomy, and lumbar interbody
fusion with orwithout screw fixation), and DM (determined by the KCD codes E10-14 and the
drug codes for DM). The comorbidity factors were HTN (determined by the KCD codes I10-
15 and the drug codes for HTN), CKD (determined by the KCD code N18), CVD (determined
by the KCD codes I20-25), and CbVD (determined by the KCD codes I60-69). Other variables
included medical cost and hospitalization time for LSS, which reflects economic burden to
patients. Medical cost, as total healthcare expenditure, was calculated as the sum of costs to
treat LSS, including outpatient clinics, pain clinics, pain medication, hospital admission, etc.,
for an 8-year follow-up period. Medical cost was calculated in Korean won (KRW) and con-
verted to US dollars (USD) using the average exchange rate for 2015. Hospitalization time was
calculated as the sum of hospital admission days for LSS.
Statistical analysis
Pearson’s chi-square tests were performed to examine differences between the DM and non-
DM groups. Comorbidities were used to obtain the hazard ratios (HRs) and 95% confidence
Fig 1. Flowchart of the study population. LSS, lumbar spinal stenosis.
https://doi.org/10.1371/journal.pone.0213858.g001
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intervals (CIs) by performing univariate and multivariate Cox proportional hazard regressions.
The overall survival rates were calculated using Kaplan-Meier curves for DM, HTN, CKD,
CVD, CbVD, and surgical management of LSS subgroups. Surgical outcomes were confirmed
using Kaplan-Meier analysis and multivariate Cox regression analysis. All reported P-values
were two-sided, and P-values of�0.05 were considered significant. Statistical analyses were
performed on SAS System for Windows version 9.4 (SAS Inc., Cary, NC, USA).
Results
The LSS incidence in Korea increased annually, with an overall 1.6-fold increase between 2002
and 2013 (8,693, 8,219, 8,542, 8,932, 8,645, 8,861, 10,011, 10,653, 10,402, 13,614, 13,947, and
13,797 in 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, and 2013, respec-
tively). Among the 14,298 patients who met the criteria and were monitored for 8 years, 3,478
patients (DM group) were compared with 10,820 patients (non-DM group). Table 1 shows the
characteristics of the DM and non-DM groups with LSS. There was a greater incidence of LSS
among women, regardless of DM. The DM group had a significantly higher association with
HTN, CVD, CKD, and CbVD than the non-DM group (86.5% vs. 65%, 53.8% vs. 39.8%, 15%
vs. 7.6%, and 61.9% vs. 43.8%, respectively). The prevalence ratio of DM in patients with LSS
was 24.3%. The overall survival rate of the DM group was 1.35 higher than that of the non-DM
group (95% CI, 1.21–1.5; p<0.001).
DM with comorbidities significantly increased the risk of mortality compared with DM
without comorbidities, based on the results of the Kaplan-Meier survival curves and log-rank
tests: HTN (HR, 1.4; 95% CI, 1.25–1.56; p<0.001), CVD (HR, 1.53; 95% CI, 1.36–1.73;
p<0.001), CKD (HR, 3.18; 95% CI, 2.7–3.76; p<0.001), and CbVD (HR, 1.69; 95% CI, 1.49–
1.91; p<0.001) (Fig 2). Among them, CKD correlated with a higher mortality rate than other
comorbidities.
Table 1. Characteristics of the DM group (n = 3,478) and non-DM group (n = 10,820).
Variables DM Non-DM P-value
Number 3,478 10,820
Mean age (years) 64.5 ± 8.0 63.5 ± 9.0 <0.0001
Sex 0.0084
Male 1,179 (33.9%) 3,420 (31.6%)
Female 2,299 (66.1%) 7,400 (68.4%)
HTN <0.0001
No 468 (13.5%) 3,780 (35%)
Yes 3,007 (86.5%) 7,028 (65%)
CVD <0.0001
No 1,605 (46.2%) 6,510 (60.2%)
Yes 1,870 (53.8%) 4,298 (39.8%)
CKD <0.0001
No 2,953 (85%) 9,982 (92.4%)
Yes 522 (15%) 826 (7.6%)
CbVD <0.0001
No 1,324 (38.1%) 6,071 (56.2%)
Yes 2,151 (61.9%) 4,737 (43.8%)
DM, diabetes mellitus; HTN, hypertension; CVD, cardiovascular disease; CKD, chronic kidney disease; CbVD,
cerebrovascular disease.
https://doi.org/10.1371/journal.pone.0213858.t001
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Table 2 shows the comparison of hospitalization time and medical expenses between the
DM and non-DM groups. The mean hospitalization time and medical expenses of the DM
group were 4.2 days longer (p = 0.0008) and 290 USD higher (p<0.001) than the controls,
respectively.
In the DM group, surgery ("surgery group") and no surgery ("non-surgery group") for LSS
were compared in terms of survival rate for prognosis, hospitalization time, and medical
expenses. Patients with LSS were significantly associated with favorable surgical outcomes
(p<0.0001). Additionally, patients with DM who underwent surgery for LSS had a signifi-
cantly better prognosis than those with DM who underwent conservative treatment
(p = 0.046) (Fig 2). There was a 31.3 day difference in hospitalization time between the surgery
and non-surgery groups, and medical expenses showed a difference of 6,207 USD between the
groups (7,127 USD and 920 USD, respectively; p<0.0001; Table 3). We compared the surgical
outcomes in LSS and LSS with DM using Kaplan-Meier analysis and multivariate cox
Fig 2. Risk of mortality from DM and comorbidities by Kaplan-Meier analysis. (a) Non-DM vs. DM. (b) DM vs. DM with HTN. (c) DM vs. DM with CVD.
(d) DM vs. DM with CKD. (e) DM vs. DM with CbVD. DM, diabetes mellitus; HTN, hypertension; CVD, cardiovascular disease; CKD, chronic kidney disease;
CbVD, cerebrovascular disease; vs., versus.
https://doi.org/10.1371/journal.pone.0213858.g002
Table 2. Comparison of length of hospital stay and medical expenses between the DM group and non-DM group in patients with lumbar spinal stenosis.
Number Hospitalization
(mean no. of days)
(min-max)
P-value Medical expenses
(average in USD)
(min-max)
P-value
DM 3,386 34.9
(1–1,318)
0.0008 1,590
(4–49,021)
<0.001
Non-DM 10,574 30.7
(0–1,336)
1,300
(6–108,060)
DM, diabetes mellitus; USD, United States dollars.
https://doi.org/10.1371/journal.pone.0213858.t002
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regression analysis. Fig 3 reveals that the survival rates for LSS and LSS with DM in the surgery
group were improved compared with the non-surgery group (HR, 0.55; 95% CI, 0.43–0.7;
p<0.001, vs. HR, 0.68; 95% CI, 0.46–1; p = 0.046). In patients with LSS, conservative treatment
showed a 1.91-fold higher mortality rate than surgical treatment, and a 1.61-fold higher mor-
tality rate in the DM group even after adjusting for all comorbidity factors (95% CI, 1.5–2.44,
p<0.001, and 95% CI, 1.09–2.37, p = 0.017, respectively; Table 4).
Discussion
This retrospective cohort study investigated the relationship between DM and LSS using a
national database. We confirmed that among patients with LSS, the DM group had a 1.35-fold
higher mortality rate than the non-DM group. There was a higher risk of mortality when DM
occurred with comorbidities such as HTN, impaired renal function, and vascular diseases.
Furthermore, we found that patients with DM with surgical management of LSS had a better
prognosis than those with DM who underwent conservative treatment.
LSS with DM vs. without DM
The prevalence of DM has been continuously increasing over time. Abraham et al. reported
that the annual rates of DM per 1,000 individuals were 2.6, 3.8, 4.7, and 3.0 for women and 3.4,
4.5, 7.4, and 7.3 for men in the 1970s, 1980s, 1990s, and 2000s, respectively [13]. Patients with
DM were estimated to account for 8.8% of the world’s population, and the International
Table 3. Comparison of length of hospital stay and medical expenses between the surgery and non-surgery subgroups of the diabetes mellitus group.
Number Hospitalization
(mean no. of days)
(min-max)
P-value Medical expenses
(average in USD)
(min-max)
P-value
With surgery 268 70.5
(1–956)
<0.0001 8,017
(8–49,305)
<0.0001
No surgery 3,118 31.8
(1–1,318)
1,048
(4–38,712)
USD, United States dollars.
https://doi.org/10.1371/journal.pone.0213858.t003
Fig 3. Surgical outcomes in (a) LSS and (b) LSS with DM by Kaplan-Meier analysis. DM, diabetes mellitus; LSS, lumbar spinal stenosis.
https://doi.org/10.1371/journal.pone.0213858.g003
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Diabetes Federation predicts that the DM population will rise to 642 million by 2040 [14]. In
Europe, morbidity from DM among the adult population is reported to be 8–10% [15]. The
World Health Organization estimated that 1.5 million deaths were directly caused by DM in
2012 and that 5 million deaths were attributed to DM in 2015 [14]. DM is a chronic disease
affecting the connective tissues, including the bone and cartilage [16,17], peripheral nervous
system, blood vessels, and intervertebral discs, causing early degeneration [18,19]. Therefore,
DM may be related to the pathogenesis of spinal stenosis [20]. In this study, 24.3% of patients
with LSS had DM, which is about 2.8-fold higher than the average DM population. Moreover,
among patients with LSS, the DM group showed a significantly higher overall survival rate
than that of the non-DM group.
DM and comorbidity
The mortality rate of patients with DM is reported to be about twofold higher than that of the
general population [2,3]. Additionally, some studies reported a tendency of risk of disease pro-
gression when DM occurs with CVD (including stroke, myocardial infarction, angina pectoris,
heart failure, ischemic heart disease, coronary heart disease, atherosclerosis, and cardiovascu-
lar death) and CKD [5,21]. In our study, DM with HTN, CVD, CKD, or CbVD showed a sig-
nificantly increased mortality rate, especially with CKD. Moreover, as we selected patients
with DM who had LSS and were aged�50 years, we can assume that poor glucose control and
low physical activity, due to neurogenic intermittent claudication and radiating leg pain, both
lead to risk of progression of comorbidities with DM. Einarson et al. reported that CVD
affected about 32% of the DM population, with coronary artery disease and stroke as the
major causes of mortality [21]. There has been also an increasing population of older DM
Table 4. Multivariate Cox regression analysis of variables according to risk of mortality in LSS and LSS with DM.
Variables Multivariate Cox (LSS) Multivariate Cox (LSS with DM)
HR 95% CI P-value HR 95% CI P-value
Group
Non-DM 1 (reference)
DM 1.12 1.0–1.25 0.049
Treatment
Surgery 1 (reference) 1 (reference)
Non-surgery 1.91 1.5–2.44 <0.001 1.61 1.09–2.37 0.017
HTN
No 1 (reference) 1 (reference)
Yes 0.9 0.8–1.02 0.09 1.05 0.78–1.42 0.73
CVD
No 1 (reference) 1 (reference)
Yes 1.64 1.48–1.82 <0.001 1.52 1.25–1.85 <0.001
CKD
No 1 (reference) 1 (reference)
Yes 2.83 2.51–3.19 <0.001 2.81 2.31–3.41 <0.001
CbVD
No 1 (reference) 1 (reference)
Yes 1.23 1.11–1.37 <0.001 1.16 0.95–1.42 0.14
DM, diabetes mellitus; LSS, lumbar spinal stenosis; HR, hazard ratio; CI, confidence interval; HTN, hypertension; CVD, cardiovascular disease; CKD, chronic kidney
disease; CbVD, cerebrovascular disease.
https://doi.org/10.1371/journal.pone.0213858.t004
The effect of diabetes mellitus on lumbar spinal stenosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0213858 March 15, 2019 7 / 11
patients with CKD due to long life expectancy and high DM incidence [22]. According to the
National Health and Nutrition Examination Survey (NHANES), the prevalence of CKD in
older patients with DM increased from 27.3% during 1988–1994 to 40.6% during 2009–2014
[23]. While the progressive decline in glomerular filtration rate (GFR) normally accompanies
aging, DM accelerates the GFR decline, leading to CKD development [24]. Furthermore, in
patients with DM, CKD increases cardiovascular morbidity and mortality and is associated
with renal replacement therapy [25]. Thus, DM is related to various comorbidities, affects
their progression, and increases mortality.
Hospitalization time and medical cost
As DM prevalence is increasing, medical expenses for DM also increase. Jacobs et al. reported
that people with DM had 1.7-fold higher health expenses than people without DM [26]. Mean-
while, LSS occurs with aging, and its prevalence is increasing with older age. Lee et al. [27]
reported an increased incidence of spinal diseases with an increase in the aging population,
with a peak incidence rate of 42.6% in the age group 75–79 years. Between 2012 and 2016, the
medical costs for spinal stenosis comprised the largest portion of expenses for spinal diseases
in patients aged>60 years [27]. In our study, we divided the patients with LSS into the DM
and non-DM groups, and compared their total lengths of hospital stay and medical expenses,
which were only associated with LSS after 8 years of follow-up. We found that LSS with DM
was significantly associated with longer hospitalization and higher medical cost. Furthermore,
hospitalization time and medical expenses were greater in the surgery group than in the non-
surgery group. Hence, DM and LSS significantly increased the healthcare burden of the
patients.
Surgical outcome of LSS patients with DM
Surgical treatment of LSS has been consistently reported to bring about reliable positive results
[28,29]. However, DM is closely associated with postoperative surgical site infection, leading
to a worse prognosis. Fei et al. reported that DM is the most important predictor of surgical
site infection after lumbar spinal surgery [30]. Moreover, recently, surgical management of
LSS demonstrated questionable benefits compared with conservative treatment, with the rate
of side effects ranging from 10% to 24% in surgical cases and no side effects for conservative
treatment [31]. Here, in the DM group, surgical management of LSS was significantly associ-
ated with better prognosis, and we found similar results in the total LSS population after
adjusting for comorbidities. In contrast to previous studies, this study produced meaningful
results on surgical outcomes, which were possible through using operational definitions to
reduce bias, using a large national sample, and performing a long-term observation.
Limitations
This population-based study has some limitations. First, we used insurance claims data, which
lacked information about the patient’s laboratory findings and lifestyle factors related to DM,
and nonreimbursable items, which included nonsurgical treatments, procedures, and medi-
cines not covered by the Korean health insurance system. Second, the medical expenses could
be inaccurate due to the type of populations and diagnostic codes included by the insurance
claims. Only medical expenditures by beneficiaries of KNHIS were covered, whereas those
with Medicaid were not. Moreover, the medical costs were calculated from insurance claims
stating LSS as the “main diagnosis” and “second diagnosis”. For these reasons, there was possi-
bility of underestimating medical expenses. Nevertheless, we used operational definitions for
LSS, DM, and comorbidities to improve diagnostic reliability.
The effect of diabetes mellitus on lumbar spinal stenosis
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Conclusions
Patients with DM who had LSS showed a poor prognosis when DM occurred with HTN, CVD,
and CbVD, and most significantly with CKD. Although LSS with DM was negatively associated
with hospitalization time, medical cost, and mortality, surgical treatment for LSS in patients
with DM was associated with a favorable prognosis compared with conservative treatment.
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